Your browser version may not work well with NCBI's Web applications. More information here...
1: Br J Cancer. 2005 Nov 28;93(11):1305-6.Click here to read Links
Comment in:
Br J Cancer. 2006 Jun 19;94(12):1948; author reply 1949-50.

Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort.

Newton R, Ribeiro T, Casabonne D, Alvarez E, Touzé A, Key T, Coursaget P.

Epidemiology & Genetics Unit, Department of Health Sciences, Heslington, York, UK. Rob.newton@egu.york.ac.uk

In a case-control study nested within the EPIC-Oxford cohort, there were no statistically significant differences in the prevalence or titre of antibodies against BK virus measured in plasma taken prior to diagnosis between cases with cancer of the prostate (n=31), kidney (n=5) or bladder (n=9) and controls (n=45).

PMID: 16304559 [PubMed - indexed for MEDLINE]